341
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Association of paraoxonase 1 (PON1) gene polymorphisms and concentration with essential hypertension

, , , , , , & show all
Pages 602-607 | Received 19 Feb 2016, Accepted 04 Mar 2016, Published online: 26 Sep 2016

References

  • Kumar A. Correlation of serum paraoxonase activities in known cases of 130 elderly hypertensive South Asian aged 56–64 years – a hospital based study. Asian Pac J Trop Dis 2014;4:S330–S5.
  • Oparil S, Zaman MA, Calhoun DA. Pathogenesis of hypertension. Ann Intern Med 2003;139(9):761–76.
  • Dell’Omo G, Penno G, Pucci L, et al. Q192R Paraoxonase (PON)1 Polymorphism, Insulin Sensitivity, and Endothelial Function in Essential Hypertensive Men. Clin Med Insights Cardiol 2014;8:57–62.
  • Sagar S, Kallo IJ, Kaul N, Ganguly NK, Sharma BK. Oxygen free radicals in essential hypertension. Mol Cell Biochem 1992;111(1–2):103–8.
  • Vaziri ND. Causal link between oxidative stress, inflammation, and hypertension. Iran J Kidney Dis 2008;2(1):1–10.
  • Assadpoor-Piranfar M, Pordal AH, Beyranvand MR. Measurement of oxidized low-density lipoprotein and superoxide dismutase activity in patients with hypertension. Arch Iran Med 2009;12(2):116–20.
  • Campo S, Sardo MA, Trimarchi G, et al. Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians. Exp Gerontol. 2004;39(7):1089–94.
  • Marra M, Marchegiani F, Antonicelli R, et al. The PON1192RR genotype is associated with a higher prevalence of arterial hypertension. J Hypertens 2006;24(7):1293–8.
  • Xie S, Li J, Chen Y, et al. Sequence identification, chromosomal mapping and tissue specific expression of the porcine paraoxonase 1 (PON1) gene. Mol Biol Rep 2010;37(3):1347–53.
  • Playfer JR, Eze LC, Bullen MF, Evans DA. Genetic polymorphism and interethnic variability of plasma paroxonase activity. J Med Genet 1976;13(5):337–42.
  • Goswami B, Tayal D, Gupta N, Mallika V. Paraoxonase: a multifaceted biomolecule. Clin Chim Acta 2009;4107.
  • Adkins S, Gan KN, Mody M, La Du BN. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. Am J Hum Genet 1993;52(3):598–608.
  • Deakin S, Leviev I, Brulhart-Meynet MC, James RW. Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position - 107, implicating the Sp1 transcription factor. Biochem J 2003;372(Pt 2):643–9.
  • Leviev I, James RW. Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. Arteriosclerosis Thrombosis Vasc Biol 2000;20(2):516–21.
  • Suzuki H, DeLano FA, Parks DA, et al. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc Natl Acad Sci U S A 1998;95(8):4754–9.
  • Beswick RA, Dorrance AM, Leite R, Webb RC. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertens 2001;38(5):1107–11.
  • Livak KJ. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal Biomol Eng 1999;14(5–6):143–9.
  • Lacy F, Kailasam MT, O’Connor DT, et al. Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertens 2000;36(5):878–84.
  • Rodrigo R, Gonzalez J, Paoletto F. The role of oxidative stress in the pathophysiology of hypertension. Hypertens Research 2011;34(4):431–40.
  • Tanito M, Nakamura H, Kwon YW, et al. Enhanced oxidative stress and impaired thioredoxin expression in spontaneously hypertensive rats. Antioxid Redox Signaling 2004;6(1):89–97.
  • Ates I, Ozkayar N, Topcuoglu C, Dede F. Relationship between oxidative stress parameters and asymptomatic organ damage in hypertensive patients without diabetes mellitus. Scand Cardiovasc J SCJ. 2015;49(5):249–56.
  • Uzun H, Karter Y, Aydin S, et al. Oxidative stress in white coat hypertension; role of paraoxonase. J Hum Hypertens 2004;18(7):523–8.
  • Barath A, Nemeth I, Karg E, et al. Roles of paraoxonase and oxidative stress in adolescents with uraemic, essential or obesity-induced hypertension. Kidney Blood Press Res. 2006;29(3):144–51.
  • Chen X, Wu Y, Liu L, et al. Relationship between high density lipoprotein antioxidant activity and carotid arterial intima-media thickness in patients with essential hypertension. Clin Exp Hypertens 2010;32(1):13–20.
  • Aynacioglu AS, Kepekci Y. The human paraoxonase Gln-Arg192 (Q/R) polymorphism in Turkish patients with coronary artery disease. Int J Cardiol 2000;74(1):33–7.
  • Demirdogen BC, Demirkaya S, Turkanoglu A, et al. Analysis of paraoxonase 1 (PON1) genetic polymorphisms and activities as risk factors for ischemic stroke in Turkish population. Cell Biochem Funct 2009;27(8):558–67.
  • Sayin Kocakap DB, Dogru MT, Simsek V, et al. The association of paraoxonase 1 gene L55M polymorphism with the extent and severity of coronary artery disease in the Turkish population and its dependence on gender. Anatolian J Cardiol 2015 DOI:10.5152/akd.2015.6010.
  • Bhatnagar V, Liu L, Nievergelt CM, et al. Paraoxonase 1 (PON1) C/T-108 association with longitudinal mean arterial blood pressure. Am J Hypertens 2012;25(11):1188–94.
  • Mackness B, Mackness MI, Arrol S, et al. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS lett 1998;423(1):57–60.
  • Brophy VH, Jampsa RL, Clendenning JB, et al. Effects of 5’ regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. Am J Hum Genet. 2001;68(6):1428–36.
  • Jarvik GP, Tsai NT, McKinstry LA, et al. Vitamin C and E intake is associated with increased paraoxonase activity. Arteriosclerosis Thrombosis Vasc Biol 2002;22(8):1329–33.
  • Rao MN, Marmillot P, Gong M, et al. Light, but not heavy alcohol drinking, stimulates paraoxonase by upregulating liver mRNA in rats and humans. Metab Clin Exp 2003;52(10):1287–94.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.